Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia-prospective, Nationwide, Multi-center Study

NCT06184009 is registered in ClinicalTrials.gov with Jae Wook Lee as lead sponsor.

NCT NCT06184009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06184009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia-prospective, Nationwide, Multi-center Study
Lead sponsor
Jae Wook Lee
Phase
Phase 2
Overall status
Recruiting
Start date
August 10, 2024
Completion date
December 31, 2030
Enrollment
370 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric acute lymphoblastic leukemia